Novel markers of early neutrophilic and monocytic engraftment after hematopoietic stem cell transplantation

Annals of Laboratory Medicine

Volumn 34, Issue 2, 2014, Pages 92-97

  Kahng, Jimin ^a   Yahng, Seung Ah ^a   Lee, Jae Wook ^a   Kim, Yonggoo ^a   Kim, Myungshin ^a   Oh, Eun Jee ^a   Park, Yeon Joon ^a   Lee, Jong Wook ^a   Cho, Bin ^a   Han, Kyungja ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Engraftment; HSCT; Marker; Monocytes; Neutrophils

Indexed keywords

ADOLESCENT; ADULT; ALLOTRANSPLANTATION; AUTOTRANSPLANTATION; CHILD; CYTOLOGY; FEMALE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFANT; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTE; NEUTROPHIL; PRESCHOOL CHILD; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHILS; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84897848035     PISSN: 22343806     EISSN: 22343814     Source Type: Journal    
DOI: 10.3343/alm.2014.34.2.92     Document Type: Article

References (17)

1. Clift RA, Buckner CD, Thomas ED, Bensinger WI, Bowden R, Bryant E, et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 1994;84:2036-43.
2. Noronha JF, De Souza CA, Vigorito AC, Aranha FJ, Zulli R, Miranda EC, et al. Immature reticulocytes as an early predictor of engraftment in autologous and allogeneic bone marrow transplantation. Clin Lab Haematol 2003;25:47-54.
3. Flowers CR, Seidenfeld J, Bow EJ, Karten C, Gleason C, Hawley DK, et al. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2013;31:794-810.
4. Phillips R, Hancock B, Graham J, Bromham N, Jin H, Berendse S. Prevention and management of neutropenic sepsis in patients with cancer: summary of NICE guidance. B MJ 2012;345:e5368.
5. Grazziutti ML, Dong L, Miceli MH, Cottler-Fox M, Krishna SG, Fassas A, et al. Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipients. Bone Marrow Transplannt 2006;37:403-9.
6. Storek J, Geddes M, Khan F, Huard B, Helg C, Chalandon Y, et al. Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol 2008;30:425-37.
7. Lee HK, Kim SI, Chae H, Kim M, Lim J, Oh EJ, et al. Sensitive detection and accurate monitoring of Plasmodium vivax parasites on routine complete blood count using automatic blood cell analyzer (DxH800(TM)). Int J Lab Hematol 2012;34:201-7.
8. Lee JC, Ahern TP, Chaves FP, Quillen K. Utility of hematologic and volume, conductivity, and scatter parameters from umbilical cord blood in predicting chorioamnionitis. Int J Lab Hematol 2010;32:351-9.
9. Mardi D, Fwity B, Lobmann R, Ambrosch A. Mean cell volume of neutrophils and monocytes compared with C-reactive protein, interleukin-6 and white blood cell count for prediction of sepsis and nonsystemic bacterial infections. Int J Lab Hematol 2010;32:410-8.
10. Park DH, Park K, Park J, Park HH, Chae H, Lim J, et al. Screening of sepsis using leukocyte cell population data from the Coulter automatic blood cell analyzer DxH800. Int J Lab Hematol 2011;33:391-9.
11. Thomas ED, Storb R, Clift RA, Fefer A, Johnson L, Neiman PE, et al. Bone-marrow transplantation (second of two parts). N Engl J Med 1975;292:895-902.
12. Begemann PG, Hassan HT, Kröger N, Krüger W, Kabisch H, Zander AR. Correlation of time to platelet engraftment with amount of transplanted CD34+CD41+ cells after allogeneic bone marrow transplantation. J Hematother Stem Cell Res 2002;11:321-6.
13. Chae YS, Jeon SB, Sung WJ, Lim JW, Kim DH, Kim JG, et al. Clinical outcomes according to transplanted CD34+cell dose in allogeneic peripheral blood stem cell transplantation. Korean J Hematol 2003;38:24-31.
14. Borzy MS, Magenis E, Tomar D. Bone marrow transplantation for severe combined immune deficiency in an infant with chimerism due to intrauterine-derived maternal lymphocytes: donor engraftment documented by chromosomal marker studies. Am J Med Genet 1984;18:527-39.
15. Rothberg PG, Gamis AS, Baker D. Use of DNA polymorphisms to monitor engraftment after allogeneic bone marrow transplantation. Clin Lab Med 1997;17:109-18.
16. Dubovsky J, Daxberger H, Fritsch G, Printz D, Peters C, Matthes S, et al. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection. Leukemia 1999;13:2059, 2060-9.
17. Kim HY, Kim HJ, Ki CS, Kim DW, Yoo KH, Kang ES. Rapid determination of chimerism status using dihydrorhodamine assay in a patient with X-linked chronic granulomatous disease following hematopoietic stem cell transplantation. Ann Lab Med 2013;33:288-92.